TAKAO MASAKI

Last Updated :2026/08/05

Affiliations, Positions
Hiroshima University Hospital, Professor
E-mail
masakithiroshima-u.ac.jp
Self-introduction
My speciality is Nephrology.

Basic Information

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Kidney internal medicine

Affiliated Academic Societies

  • The Japanese Society of Internal Medicine Japanese Society of Nephrology The Japanese Society for Dialysis Therapy The Japanese Association of Rehabilitation Medicine Japanese Society for Peritoneal Dialysis Japanese Society for Hemodiafiltration American Society of Nephrology International Society of Nephrology European Renal Association

Educational Activity

Course in Charge

  1. 2026, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2026, Undergraduate Education, Intensive, Practice for medical research
  3. 2026, Undergraduate Education, Intensive, Practice of Medicine I
  4. 2026, Undergraduate Education, Intensive, Practice of Medicine II
  5. 2026, Graduate Education (Master's Program) , 1Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance A
  6. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Nephrology
  7. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Nephrology
  8. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Nephrology
  9. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Nephrology

Research Activities

Academic Papers

  1. Predicting 3-year all-cause mortality in patients undergoing hemodialysis using machine learning., J Nephrol., 38(3), 1017-1024, 202505
  2. A Case of Acute Kidney Injury and Fanconi Syndrome Caused by a Red Yeast Rice Supplement., Intern Med., 64(16), 2472-2477, 202502
  3. Temporal and Demographic Trends in Biopsy-Proven Kidney Disease Diagnoses in the Southwestern United States, 1993-2022, KIDNEY MEDICINE, 7(12), 202512
  4. Hypomagnesaemia-associated hypokalaemia requires activation of both ENaC and ROMK, JOURNAL OF PHYSIOLOGY-LONDON, 603(22), 7365-7382, 202511
  5. Rapid increase in erythropoiesis-stimulating agent resistance is a risk factor for poor renal prognosis in patients with chronic kidney disease pre-dialysis: A BRIGHTEN study sub-analysis, PLOS ONE, 20(11), 20251121
  6. Potential Association Between Darbepoetin Alfa Administration and Reduced Proteinuria in Real-World Clinical Practice: A Post Hoc Analysis of the BRIGHTEN Study, NEPHROLOGY, 30(10), 202510
  7. Early use of renin-angiotensin-aldosterone system inhibitors and stable renal function in familial focal segmental glomerulosclerosis with ACTN4 mutation: a case report and literature review, BMC NEPHROLOGY, 26(1), 20250926
  8. Epigenetic histone modifications in kidney disease and epigenetic memory, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 29(9), 1129-1138, 202509
  9. Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis, NEPHROLOGY DIALYSIS TRANSPLANTATION, 40(8), 1538-1549, 202508
  10. Effectiveness of switching from nalfurafine to difelikefalin in patients with hemodialysis-associated pruritus: a prospective interventional study within a new treatment algorithm, RENAL REPLACEMENT THERAPY, 11(1), 20250708
  11. Targeting MLL1/WDR5-Mediated Epigenetic Regulation Mitigates Peritoneal Fibrosis by Reducing p16INK4a, FASEB JOURNAL, 39(8), 20250430
  12. Renal protective effects of extracellular vesicle-encapsulated tumor necrosis factor-α-induced protein 6 derived from mesenchymal stem cells, STEM CELLS, 43(5), 202505
  13. Successful treatment of severe renal failure caused by malignant hypertension using a combination of renin-angiotensin-aldosterone system inhibitors: a case report, CEN CASE REPORTS, 14(2), 200-207, 202504
  14. Early arteriovenous fistula failure associated with mortality and major adverse cardiovascular events in patients undergoing incident hemodialysis, JOURNAL OF VASCULAR ACCESS, 26(1), 175-181, 202501
  15. Polycythemia secondary to bilaterally enlarged kidneys in T-Cell acute lymphoblastic leukemia: a case report and literature review, BMC NEPHROLOGY, 26(1), 20250306
  16. Peritoneal dialysis-associated polymicrobial peritonitis with slow onset after root canal treatment: the first case and review of the literature, BMC NEPHROLOGY, 26(1), 20250313
  17. Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review, BIOMEDICINES, 13(1), 202501
  18. Peritoneal dialysis-associated peritonitis, caused by superior mesenteric artery thrombosis with intestinal necrosis: a case report, CEN CASE REPORTS, 14(1), 1-5, 202502
  19. Early arteriovenous fistula failure associated with mortality and major adverse cardiovascular events in patients undergoing incident hemodialysis., J Vasc Access., 202312
  20. THE APOPROTEIN E (APOE) POLYMORPHISM AND PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) IN HEMODIALYSIS (HD) PATIENTS, Nephrology Dialysis Transplantation, 38((1)), 202306
  21. Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction, SCIENTIFIC REPORTS, 14(1), 20240504
  22. Comparison of the pre-dilution and post-dilution methods for online hemodiafiltration, JOURNAL OF ARTIFICIAL ORGANS, 27(1), 48-56, 202403
  23. Encapsulating Peritoneal Sclerosis 43 Years after Distal Gastrectomy for Early Gastric Cancer, INTERNAL MEDICINE, 63(5), 659-663, 2024
  24. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects, STEM CELL RESEARCH & THERAPY, 14(1), 20231122
  25. Comparison of the Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(23), 202312
  26. Efficacy of polymethylmethacrylate membrane hemodiafilter Filtryzer((R)) PMFTM-21A in improving pruritus in hemodialysis patients: a prospective interventional study, RENAL REPLACEMENT THERAPY, 9(1), 20230804
  27. Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis C, INTERNAL MEDICINE, 62(13), 1999-2004, 2023
  28. Nephrotic-range proteinuria and membranoproliferative glomerulonephritis-like pattern caused by interferon-beta 1b in a patient with multiple sclerosis, CEN CASE REPORTS, 12(3), 275-280, 202308
  29. Comparison of therapeutic effects of mesenchymal stem cells derived from superficial and deep subcutaneous adipose tissues, STEM CELL RESEARCH & THERAPY, 14(1), 20230504
  30. Cumulative Dialytic Glucose Exposure is a Risk Factor for Peritoneal Fibrosis and Angiogenesis in Pediatric Patients Undergoing Peritoneal Dialysis Using Neutral-pH Fluids, Kidney Int Rep, 7(11), 2431-2445, 20220903
  31. Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study, PLoS One, 17(11), 20221129
  32. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients, Am J Nephrol ., 53(2-3), 169-175, 2022
  33. Klotho protects chromosomal DNA from radiation-induced damage, JOURNAL OF BIOCHEMISTRY, 173(5), 375-382, 20230426
  34. Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 27(5), 419-426, 202305
  35. alpha 1-and beta 2-Microglobulin reduction ratios and survival in patients on predilution online haemodiafiltration, NEPHROLOGY, 28(1), 44-50, 202301
  36. A case report of atypical anti-glomerular basement membrane disease, BMC NEPHROLOGY, 23(1), 20221119
  37. The hypoxia-inducible factor-alpha prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 323(5), F539-F552, 202211
  38. N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 26(11), 1111-1118, 202211
  39. Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney disease, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 26(9), 880-885, 202209
  40. Penile calciphylaxis in patients with end-stage kidney disease undergoing dialysis: Invasive treatment and pain management, THERAPEUTIC APHERESIS AND DIALYSIS, 26(5), 950-959, 202210
  41. Coronary artery calcification is a risk factor for intradialytic hypotension in patients undergoing hemodialysis, HEMODIALYSIS INTERNATIONAL, 26(3), 335-344, 202207
  42. Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in Rats, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(14), 7831-7831, 202207
  43. Synergistic Effects of the Geriatric Nutritional Risk Index and the Modified Creatinine Index for Predicting Mortality in Patients on Hemodialysis, NUTRIENTS, 14(12), 2398-2398, 202206
  44. Convection volume, beta 2-microglobulin and alpha 1-microglobulin reduction ratios, and body composition in pre-dilution online haemodiafiltration, NEPHROLOGY, 27(7), 601-609, 202207
  45. A Combination of Iohexol Treatment and Ionizing Radiation Exposure Enhances Kidney Injury in Contrast-Induced Nephropathy by Increasing DNA Damage, RADIATION RESEARCH, 197(4), 384-395, 202204
  46. COVID-19-associated pulmonary aspergillosis in hemodialysis patients, CLINICAL KIDNEY JOURNAL, 15(5), 985-991, 20220429
  47. 15-Deoxy-Delta 12,14-prostaglandin J(2) Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells, THERAPEUTIC APHERESIS AND DIALYSIS, 14(1), 43-51, 201002
  48. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling, KIDNEY INTERNATIONAL, 84(2), 297-307, 201308
  49. PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation., Clin Exp Immunol, 144(2), 353-361, 20060501
  50. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis, The International Journal of Artificial Organs, 22(1), 14-17, 19990401
  51. ★, Tenascin expression may reflect the activity and chronicity of human IgA nephropathy., 50(4), 205-213, 19981001
  52. Role of tenascin in human immunoglobulin A nephropathy., 25(5), 247-254, 19970901
  53. The influence of steroid therapy in patients with IgA nephropathy., Nephron, 86(6), 197-198, 20001001
  54. Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney., Kidney International, 63(4), 1256-1264, 20030401
  55. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis., Nephrology Dialysis Transplantation, 18(1), 178-181, 20030101
  56. Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies., Journal of the American Society of Nephrology, 15(7), 1835-1843, 20040601
  57. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis., Clin Exp Nephrol, 20130701
  58. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 201212
  59. Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats, PLOS ONE, 9(4), 20140402
  60. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(2), 189-193, 201404
  61. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(3), 499-506, 201406
  62. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, 201412
  63. Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome, CLINICAL NEPHROLOGY, 82(4), 268-272, 201410
  64. The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, INTERNAL MEDICINE, 54(8), 887-894, 2015
  65. Hemodialysis Immediately After Cardiac Catheterization Is a Risk Factor for Intradialytic Hypotension, THERAPEUTIC APHERESIS AND DIALYSIS, 19(3), 245-249, 201506
  66. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(5), 830-837, 201510
  67. Vascular access intervention by a nephrologist in Hiroshima, JOURNAL OF VASCULAR ACCESS, 16, S58-S61, 201511
  68. Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model., Nephron Exp Nephrol, 112(2), 59-69, 2009
  69. Effect of AST-120, an oral adsorbrnt, on inhibition of the loss of renal function in CRF patients, NEPHROLOGY DIALYSIS TRANSPLANTATION, 21, 383-383, 2006
  70. Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2, THERAPEUTIC APHERESIS AND DIALYSIS, 11(2), 94-100, 2007
  71. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction, NEPHROLOGY, 12(6), 565-571, 2007
  72. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury, TRANSPLANTATION, 84(2), 207-213, 2007
  73. Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice., PLoS One., 11(8), e0160993, 20160811
  74. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study., Hemodial Int, 20(4), 580-588, 201610
  75. Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice, PLOS ONE, 11(8), 20160811
  76. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study, HEMODIALYSIS INTERNATIONAL, 20(4), 580-588, 201610
  77. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, 201611
  78. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(6), 918-925, 201612
  79. Seasonal variation in hemodialysis initiation: A single-center retrospective analysis, PLOS ONE, 12(5), 20170602
  80. AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations, CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 7(2), 102-107, 2017
  81. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients, THERAPEUTIC APHERESIS AND DIALYSIS, 12(3), 232-236, 2008
  82. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis, NEPHROLOGY DIALYSIS TRANSPLANTATION, 23(11), 3418-3426, 2008
  83. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta, LABORATORY INVESTIGATION, 89(1), 47-58, 2009
  84. Mizoribine Suppresses the Progression of Experimental Peritoneal Fibrosis in a Rat Model, NEPHRON EXPERIMENTAL NEPHROLOGY, 112(2), E59-E69, 2009
  85. C-C Chemokine Receptor 2 Expression by Circulating Monocytes Influences Atherosclerosis in Patients on Chronic Hemodialysis, THERAPEUTIC APHERESIS AND DIALYSIS, 13(3), 205-212, 2009
  86. 15-Deoxy-Delta 12,14-prostaglandin J(2) Inhibits Angiotensin II-induced Fibronectin Expression via Hepatocyte Growth Factor Induction in Human Peritoneal Mesothelial Cells, THERAPEUTIC APHERESIS AND DIALYSIS, 14(1), 43-51, 2010
  87. A SUPER HIGH-FLUX DIALYZER (PS: APS-EA) ELIMINATES 40% OF INJECTED RECOMBINANT HUMAN (RH) ERITHROPOIETIN (EPO) DURING 4-HOUR HEMODIALYSIS (HD), NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 213-213, 2012
  88. PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETERODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH LIPOPROTEINS, NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 215-216, 2012
  89. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 2012
  90. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling, KIDNEY INTERNATIONAL, 84(2), 297-307, 2013
  91. Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats, PLOS ONE, 9(4), 2014
  92. Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(2), 189-193, 2014
  93. Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(3), 499-506, 2014
  94. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, 2014
  95. Successful treatment with plasma exchange for ANCA-negative pauci-immune crescentic glomerulonephritis with D-negative hemolytic uremic syndrome, CLINICAL NEPHROLOGY, 82(4), 268-272, 2014
  96. The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, INTERNAL MEDICINE, 54(8), 887-894, 2015
  97. Hemodialysis Immediately After Cardiac Catheterization Is a Risk Factor for Intradialytic Hypotension, THERAPEUTIC APHERESIS AND DIALYSIS, 19(3), 245-249, 2015
  98. Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(4), 631-638, 2015
  99. Expression of age-related factors during the development of renal damage in patients with IgA nephropathy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(5), 830-837, 2015
  100. Vascular access intervention by a nephrologist in Hiroshima, JOURNAL OF VASCULAR ACCESS, 16, S58-S61, 2015
  101. Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 27(1), 203-215, 2016
  102. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression, KIDNEY INTERNATIONAL, 89(1), 147-157, 2016
  103. High glucose promotes TGF-beta 1 production by inducing FOS expression in human peritoneal mesothelial cells, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(1), 30-38, 2016
  104. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis., Clin Exp Nephrol, 2017
  105. Valproic acid attenuates renal fibrosis through the induction of autophagy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 21(5), 771-780, 201710
  106. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients, NEPHROLOGY, 22(12), 947-953, 201712
  107. Diffuse large B-cell lymphoma presenting as bilateral renal infiltration leading to acute kidney injury, CEN CASE REPORTS, 6(2), 140-147, 201711
  108. Protective Effects of Japanese Soybean Paste (Miso) on Stroke in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP), AMERICAN JOURNAL OF HYPERTENSION, 31(1), 43-47, 201801
  109. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 78-84, 201802
  110. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 22(1), 31-39, 201802
  111. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta(1) pathways, SCIENTIFIC REPORTS, 7, 20170515
  112. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients, INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 41(3), 135-143, 201803
  113. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report, BMC NEPHROLOGY, 19, 20180503
  114. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLOS ONE, 13(5), 20180503
  115. A case of immunotactoid glomerulopathy with false-negative IgG staining, BMC NEPHROLOGY, 19, 20180615
  116. High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 835-842, 201808
  117. Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II, CELL DEATH & DISEASE, 9(808), 20180724
  118. Klotho as a Therapeutic Target during the Development of Renal Fibrosis, SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 189, 178-183, 2017
  119. Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(2), 300-312, 2018
  120. Dec1 and CLOCK Regulate Na+/K+-ATPase 1 Subunit Expression and Blood Pressure, HYPERTENSION, 72(3), 746-754, 201809
  121. A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene, kidney Int Rep, 2(5), 969-972, 2017
  122. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, Nephrology (Carlton), 23(9), 837-845, 2018
  123. AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations., Case Rep Nephrol Dial, 7, 102-107, 2017
  124. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, NEPHROLOGY, 23(9), 837-845, 201809
  125. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction, PLOS ONE, 13(8), 20180816
  126. Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study), JOURNAL OF VASCULAR ACCESS, 19(5), 477-483, 201809
  127. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(5), 1167-1173, 201810
  128. TGF-beta 1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA, SCIENTIFIC REPORTS, 8, 20180919
  129. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis, STEM CELLS TRANSLATIONAL MEDICINE, 7(12), 893-905, 201812
  130. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells, JOURNAL OF BIOLOGICAL CHEMISTRY, 294(1), 101-115, 20190104
  131. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(12), 201812
  132. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 201809
  133. Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan, JOURNAL OF ARTIFICIAL ORGANS, 22(2), 146-153, 201906
  134. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis, PLOS ONE, 12(3), 20170309
  135. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(6), 1043-1052, 201906
  136. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(1), 217-223, 20190618
  137. Renal medullary tonicity regulates RNF183 expression in the collecting ducts via NFAT5, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(2), 436-442, 20190625
  138. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress, PLOS ONE, 14(6), 20190614
  139. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice, DIABETOLOGY & METABOLIC SYNDROME, 11, 20190722
  140. Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis, CEN CASE REPORTS, 8(3), 194-199, 201908
  141. High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study, PLOS ONE, 14(8), 20190801
  142. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients, RENAL FAILURE, 41(1), 770-777, 20190101
  143. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a), KIDNEY INTERNATIONAL, 96(5), 1162-1175, 201911
  144. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(9), 1592-1596, 201909
  145. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(19), 201910
  146. Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease, THERAPEUTIC APHERESIS AND DIALYSIS, 23(6), 534-541, 201912
  147. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma, CEN CASE REPORTS, 9(1), 48-54, 202002
  148. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli, CEN CASE REPORTS, 8(4), 266-270, 201911
  149. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells., J Biol Chem, 294(1), 101-115, 2019/1/4
  150. Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan, JOURNAL OF ARTIFICIAL ORGANS, 22(2), 146-153, 2019
  151. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study, HEMODIALYSIS INTERNATIONAL, 20(4), 580-588, 2016
  152. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20(6), 918-925, 2016
  153. Seasonal variation in hemodialysis initiation: A single-center retrospective analysis, PLOS ONE, 12(6), 2017
  154. A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene, KIDNEY INTERNATIONAL REPORTS, 2(5), 969-972, 2017
  155. Protective Effects of Japanese Soybean Paste (Miso) on Stroke in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP), AMERICAN JOURNAL OF HYPERTENSION, 31(1), 43-47, 2018
  156. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 78-84, 2018
  157. Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (vol 22, pg 78, 2018), CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(1), 85-86, 2018
  158. A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-alpha and TGF-beta(1) pathways, SCIENTIFIC REPORTS, 7, 2017
  159. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report, BMC NEPHROLOGY, 19, 2018
  160. A case of immunotactoid glomerulopathy with false-negative IgG staining, BMC NEPHROLOGY, 19, 2018
  161. A consensus statement on health-care transition of patients with childhood-onset chronic kidney diseases: providing adequate medical care in adolescence and young adulthood, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 743-751, 2018
  162. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 2018
  163. Comparing the 12-month patency of low- versus high-pressure dilation in failing arteriovenous fistulae: A prospective multicenter trial (YOROI study), JOURNAL OF VASCULAR ACCESS, 19(5), 477-483, 2018
  164. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(5), 1167-1173, 2018
  165. TGF-beta 1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRA, SCIENTIFIC REPORTS, 8, 2018
  166. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis, STEM CELLS TRANSLATIONAL MEDICINE, 7(12), 893-905, 2018
  167. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(12), 2018
  168. Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(1), 217-223, 2019
  169. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(6), 1043-1052, 2019
  170. Renal medullary tonicity regulates RNF183 expression in the collecting ducts via NFAT5, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 514(2), 436-442, 2019
  171. microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress, PLOS ONE, 14(6), 2019
  172. Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice, DIABETOLOGY & METABOLIC SYNDROME, 11, 2019
  173. High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study, PLOS ONE, 14(8), 2019
  174. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients, RENAL FAILURE, 41(1), 770-777, 2019
  175. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16(INK4a), KIDNEY INTERNATIONAL, 96(5), 1162-1175, 2019
  176. Vascular access management after percutaneous transluminal angioplasty using a calcium alginate sheet: a randomized controlled trial, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34(9), 1592-1596, 2019
  177. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(19), 2019
  178. ELEVATION OF SERUM BISPHENOL S (BPS) CONCENTRATIONS IN PATIENTS UNDERGOING HEMODIAYLSIS (HD) BY CHANGING DIALYZERS FROM POLYSULFONE TO POLYETHERSULFONE MEMBRANES, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 227-227, 2019
  179. THE IMPACT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON SERUM LIPID PROFILE IN HEMODIALYSIS (HD) PATIENTS, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 293-293, 2019
  180. DOCOSAHEXAENOIC ACID ADMINISTRATION INCREASES EGFR THROUGH UPREGULATION OF NNOS EXPRESSION, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 2019
  181. LDL-CHOLESTEROL LEVEL IS ASSOCIATED WITH DOWNREGULATION OF KLOTHO EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 471-471, 2019
  182. WEEKLY AND MONTHLY ERYTHROPOIESIS STIMULATING AGENTS ARE REMOVED DURING HEMODIALYSIS SESSION, NEPHROLOGY DIALYSIS TRANSPLANTATION, 34, 521-521, 2019
  183. Iliopsoas Abscess in Hemodialysis Patients With End-Stage Kidney Disease, THERAPEUTIC APHERESIS AND DIALYSIS, 23(6), 534-541, 2019
  184. Relationship of serum magnesium level with body composition and survival in hemodialysis patients, HEMODIALYSIS INTERNATIONAL, 24(1), 99-107, 2020
  185. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 24(5), 435-443, 2020
  186. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats, STEM CELL RESEARCH & THERAPY, 11(1), 130-130, 2020
  187. NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells, JOURNAL OF BIOLOGICAL CHEMISTRY, 294(1), 101-115, 2019
  188. TELOMERIC G-TAIL LENGTH AS A GOOD PREDICTOR OF CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS, NEPHROLOGY, 19, 116-117, 2014
  189. A classic variant of Fabry disease in a family with the M296I late-onset variant, CEN CASE REPORTS, 10(1), 106-110, 202102
  190. Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(2), 110-119, 202102
  191. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis, RENAL FAILURE, 43(1), 371-380, 20210101
  192. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210323
  193. Interferon-gamma enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis, SCIENTIFIC REPORTS, 11(1), 20210113
  194. Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice, PLOS ONE, 11(8), 2016
  195. Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report, CEN CASE REPORTS, 10(2), 220-225, 202105
  196. Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients, NEPHROLOGY, 26(4), 341-349, 202104
  197. Localization and Maintenance of Engrafted Mesenchymal Stem Cells Administered via Renal Artery in Kidneys with Ischemia-Reperfusion Injury, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(8), 202104
  198. Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report, CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 11(1), 36-47, 2021
  199. Effectiveness of a treatment algorithm for hemodialysis-associated pruritus in terms of changes in medications, RENAL REPLACEMENT THERAPY, 7(1), 20210526
  200. Valproic acid attenuates renal fibrosis through the induction of autophagy, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 21(5), 771-780, 2017
  201. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients, NEPHROLOGY, 22(12), 947-953, 2017
  202. Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 22(1), 31-39, 2018
  203. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients, INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 41(3), 135-143, 2018
  204. Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, PLOS ONE, 13(5), 2018
  205. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis, PLOS ONE, 12(3), 2017
  206. High-normal albuminuria and incident chronic kidney disease in a male nondiabetic population, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 22(4), 835-842, 2018
  207. Klotho as a Therapeutic Target during the Development of Renal Fibrosis, SCIENTIFIC ASPECTS OF DIALYSIS THERAPY, 189, 178-183, 2017
  208. Dec1 and CLOCK Regulate Na+/K+-ATPase 1 Subunit Expression and Blood Pressure, HYPERTENSION, 72(3), 746-754, 2018
  209. Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(2), F300-F312, 2018
  210. Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction, PLOS ONE, 13(8), 2018
  211. Coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients, NEPHROLOGY, 23(9), 837-845, 2018
  212. Eighteen-year follow-up cohort study on hepatitis B and C virus infections related long-term prognosis among hemodialysis patients in Hiroshima, Journal of Medical Virology, 20200624
  213. Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy, Intestinal Research, 202009
  214. A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytes, BMC Nephrology, 21(1), 376-376, 202008
  215. Different risk factors are associated with vascular access patency after construction and percutaneous transluminal angioplasty in patients starting hemodialysis, The Journal of Vascular Access, 22(5), 707-715, 202109
  216. Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210823
  217. Lower Geriatric Nutritional Risk Index (GNRI) Is Associated with Higher Risk of Fractures in Patients Undergoing Hemodialysis, NUTRIENTS, 13(8), 202108
  218. N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(10), 1142-1150, 202110
  219. The histopathological spectrum of kidney biopsies in patients with thymoma and myasthenia gravis: a report of 24 biopsies from a single institution, CLINICAL KIDNEY JOURNAL, 14(9), 2090-2100, 202109
  220. Klotho overexpression protects against renal aging along with suppression of transforming growth factor-beta 1 signaling pathways, AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 321(6), F799-F811, 202112
  221. Klotho deficiency intensifies hypoxia-induced expression of IFN-alpha/beta through upregulation of RIG-I in kidneys, PLOS ONE, 16(10), 2021

Invited Lecture, Oral Presentation, Poster Presentation

  1. RECENT EPIDEMIOLOGY AND CLINICAL OUTCOMES OF ENCAPSULATING PERITONEAL SCLEROSIS IN JAPAN, Yukio Maruyama, Nanae Matsuo, Yudo Tanno, Masato Ikeda, Keitaro Yokoyama, Masaaki Nakayama, Masanori Abe, Takao Masaki, Takashi Yokoo, World Congress of Nephrology 2026, 2026/03, Without Invitation, English, Yokohama,Japan
  2. Targeting Necroptosis as a Novel Strategy to Prevent Peritoneal Dysfunction, Kenji Fujii, Yosuke Osaki, Shiro Muraoka, Yujiro Maeoka, Naoki Ishiuchi, Kensuke Sasaki, Takao Masaki, World Congress of Nephrology 2026, 2026/03, Without Invitation, English, Yokohama,Japan
  3. ASSOCIATION BETWEEN REMISSION OF HEMATURIA AND SUBSEQUENT RENAL OUTCOMES IN BIOPSY-PROVEN IGA NEPHROPATHY, Aiko Okubo, Maria Yoshida, Akira Takahashi, Naoki Ishiuchi, Yosuke Osaki, Yujiro Maeoka, Kensuke Sasaki, Takao Masaki, World Congress of Nephrology 2026, 2026/03, Without Invitation, English, Yokohama,Japan
  4. PPARA MODULATOR PEMAFIBRATE AMELIORATES SALT-SENSITIVE HYPERTENSION AND HYPERTENSIVE ORGAN DAMAGE AFTER ISCHEMIA-REPERFUSION INJURY IN RATS, Kensuke Sasaki, Takeshi Ike, Maria Yoshida, Akira Takahashi, Yosuke Osaki, Naoki Ishiuchi, Aiko Okubo, Yujiro Maeoka, Takao Masaki, World Congress of Nephrology 2026, 2026/03, Without Invitation, Japanese, Yokohama,Japan
  5. Regulation of NKCC2 Phosphorylation by Hypokalemia through the PKA–DARPP-32–PP1 Pathway in the Renal Medulla, Wataru Harada, Yujiro Maeoka, Naoki Ishiuchi, Yosuke Osaki, Kensuke Sasaki, James A. McCormick,Takao Masaki, World Congress of Nephrology 2026, 2026/03, Without Invitation, Japanese
  6. A CASE OF SPORADIC KARYOMEGALIC INTERSTITIAL NEPHRITIS WITH A NOVEL FAN1 GENE MUTATION: THE FIRST REPORT IN EAST ASIA, Maria Yoshida, Yujiro Maeoka, Yasunao Kamikawa, Takeshi Ike, Kazunori Imaizumi, Toshinori Ueno,Takashi Nishisaka, Takayuki Naito, Michio Nagata, Kandai Nozu, Takayasu Mori, Eisei Sohara, Shinichi Uchida,Takao Masaki, World Congress of Nephrology 2026, 2026/03, Without Invitation, English, Yokohama,Japan
  7. Hypokalemia-Induced NKCC2 Dephosphorylation via the PKA-DARPP-32-PP1 Pathway in the Renal Medulla, Harada Wataru, Maeoka Yujiro, Ishiuchi Naoki, Osaki Yosuke, Sasaki Kensuke, McCormick James A., Masaki Takao, American Society of Nephrology 2025, 2025/11/08, Without Invitation, English
  8. Myeloid IRF4 Deficiency Attenuates Peritoneal Fibrosis by Suppressing Macrophage Migration, Sasaki Kensuke, Onoue Keiko, Ike Takeshi, Osaki Yosuke, Ishiuchi Naoki, Maeoka Yujiro, Masaki Takao, American Society of Nephrology 2025, 2025/11/08, Without Invitation, English
  9. Haematologic Effects of Long-Term Daprodustat in Patients on Maintenance Hemodialysis: A Three-Year Evaluation, Morii Kenichi, Doi Toshiki, Nishizawa Yoshiko, Yamashita Kazuomi, Mizuiri Sonoo, Masaki Takao,, American Society of Nephrology 2025, 2025/11/07, Without Invitation, English
  10. Corrected QT (QTc) Interval Prolongation, Dialysis Adequacy, Body Composition, and Coronary Artery Calcification in Patients on Hemodialysis, Mizuiri Sonoo, Nishizawa Yoshiko, Doi Toshiki, Morii Kenichi, Yamashita Kazuomi, Shigemoto Kenichiro,Masaki Takao,, American Society of Nephrology 2025, 2025/11/06, Without Invitation, English
  11. Changes in Coronary Artery Calcification Score in ESKD: Comparison of Conventional and Nocturnal Hemodialysis, Toshiki Doi, Morii Kenichi, Nishizawa Yoshiko, Mizuiri Sonoo, Yamashita Kazuomi, Masaki Takao, American Society of Nephrology 2025, 2025/11/07, Without Invitation, English
  12. Peroxisome Proliferator-Activated Receptor alpha Modulator Pemafibrate Ameliorates Salt-Sensitive Hypertension and Hypertensive Organ Damage After Ischemia-Reperfusion Injury in Rats, Ken Sasaki, Takeshi Ike, Yosuke Osaki, Naoki Ishiuti, Yujiro Maeoka, Takao Masaki, American Society of Nephrology 2025, 2025/11/06, Without Invitation, English, USA
  13. Newest renal registry data of end-stage kidney disease in Japan, Takao Masaki, The 70th Annual Meeting of the Japanese Society for Dialysis Therapy, 2025/06/27, Without Invitation, English, Osaka,Japan
  14. Serum Transferrin Levels Predict Hemodialysis (HD) Adequacy and Mortality in Patients on Maintenance Hemodialysis, Mizuiri Sonoo, Nishizawa Yoshiko, Doi Toshiki, Okubo Aiko, Morii Kenichi, Yamashita Kazuomi, Shigemoto Kenichiro, Karasuda, Kazuyoshi, Masaki Takao, American Society of Nephrology 2024, 2024/10/24, Without Invitation, English
  15. Temporal and Demographic Trends in Medical Kidney Disease Epidemiology in the Southwestern United States, 1993-2022, Takahashi Akira, Kiyozawa Daisuke, Miyauchi Takamasa, Ren Yi Mi Kevin, Doi Toshiki, Choung Hae Yoon Grace, Lin Mercury Y, Hou Jean, Masaki Takao, Oda Yoshinao, Haas Mark, Nast Cynthia C, Yamashita Michifumi, American Society of Nephrology 2024, 2024/10/25, Without Invitation, English
  16. Tenapanor, a Novel Phosphorus Absorption Inhibitor, Softens Stool Properties and Enables Good Phosphorus Management, Morii Kenichi, Doi Toshiki, Okubo Aiko, Nishizawa Yoshiko, Yamashita Kazuomi, Mizuiri Sonoo, Masaki Takao, American Society of Nephrology 2024, 2024/10/25, Without Invitation, English
  17. Associations between Femoral Neck Bone Mineral Density, Kt/Vurea, and Mortality in Patients on Hemodialysis, Mizuiri Sonoo, Nishizawa Yoshiko, Doi Toshiki, Okubo Aiko, Morii Kenichi, Yamashita Kazuomi, Shigemoto Kenichiro, Mikami Tomio, Masaki Takao, American Society of Nephrology 2024, 2024/10/25, Without Invitation, English
  18. Mesenchymal Stem Cells Overexpressing Tumor Necrosis Factor alpha-Induced Protein 6 Have an Enhanced Inhibitory Effect on Kidney Fibrosis, Morimoto Keisuke, Nakashima, Ayumu, Ishiuchi Naoki, Miyasako Kisho, Tanaka Yoshiki, Sasaki Kensuke, Masaki Takao, American Society of Nephrology 2024, 2024/10/24, Without Invitation, English
  19. Thrombomodulin-Overexpressing Adipose-Derived Mesenchymal Stem Cells Prevent Thromboembolism and Ameliorate Kidney Fibrosis in Rats, Tanaka Yoshiki, Nakashima Ayumu, Ishiuchi Naoki, Miyasako Kisho, Morimoto Keisuke, Sasaki Kensuke, Masaki Takao, American Society of Nephrology 2024, 2024/10/24, Without Invitation, English
  20. Changes in Coronary Artery Calcification Score in ESKD: Comparison of Hemodialysis and Online Hemodiafiltration, Doi Toshiki, Morii Kenichi, Okubo Aiko, Mizuiri Sonoo, Nishizawa Yoshiko, Masaki Takao, American Society of Nephrology 2024, 2024/10/24, Without Invitation, English
  21. Magnesium Protects Against CKD Progression by Reducing DNA Damage, Makoto Matsubara, Kensuke Sasaki, Naoki Ishiuchi, Yosuke Osaki, YujiroMaeoka, Takao Masaki, Kidney Health In Aging and Aged Societies: JSN/ERA Symposium Collaboration with JSDT, 2024/09/14, Without Invitation, English
  22. PPARalpha Modulator Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis, Shinkai Y ,Tamura R, Ishiuchi N, Osaki Y, Maeoka Y, Sasaki K, Masaki T, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  23. Etelcalcetide Use Affects Changes in Agatston Coronary Artery Calcium (CAC) Score in Maintenance Dialysis Patients, Doi Toshiki,Morii Kenichi,Mizuiri Sonoo,Nishizawa Yoshiko,Masaki Takao, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  24. Comparison of Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis, Yoshida Maria,Nakashima Ayumu,Ishiuchi Naoki,Miyasako Kisho,Tanaka Yoshiki,Morimoto Keisuke,Sasaki Kensuke,Masaki Takao, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  25. The Effects of Regulatory T Cell Induction by Mesenchymal Stem Cells Pretreated with Interferon-Gamma on Renal Inflammation and Fibrosis, Kurawaki So,Nakashima Ayumu,Ishiuchi Naoki,Kanai Ryo,Sasaki Kensuke,Masaki Takao, American Society of Nephrology 2023, 2023/11/04, Without Invitation, English
  26. Magnesium Protects Against CKD Progression by Reducing DNA Damage, Matsubara M, Sasaki K, Ishiuchi N, Takahashi A, Osaki Y, Maeoka Y, Masaki T, American Society of Nephrology 2023, 2023/11/03, Without Invitation, English
  27. Red Blood Cell Distribution Width-Coefficient of Variation as an Indicator of the Requirement for and Efficacy of Daprodustat in Hemodialysis Patients Switching from Erythropoietin-Stimulating Agents, Morii Kenichi, Doi Toshiki, Nishizawa Yoshiko, Yamashita Kazuomi, Shigemoto enichiro, Mizuiri Sonoo, Masaki Takao, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  28. Coronary Artery Calcification Is Associated with Low Kt/Vurea and Extracellular Fluid Excess in Patients on Hemodialysis, Mizuiri Sonoo, Nishizawa Yoshiko, Doi Toshiki,Okubo Aiko, Morii Kenichi, Yamashita Kazuomi, Karasuda Kazuyoshi, Usui Koji, Shigemoto Kenichiro, Masaki Takao, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  29. Absolute Iron Deficiency, Coronary Artery Calcification, and Mortality in Dialysis Patients, Mizuiri Sonoo,Nishizawa Yoshiko, Doi Toshiki, Okubo Aiko, Morii Kenichi, Yamashita Kazuomi, Usui Koji, Shigemoto Kenichiro, Masaki Takao, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  30. Rapidly Increased Pattern of Erythropoiesis⁻Stimulating Agent (ESA) Resistance Is a Predictor of Poor Renal Prognosis in Predialysis CKD Patients: BRIGHTEN Study Subanalysis, Kawamoto Shinya, Masaki Takao, Maruyama Shoichi, Yamakawa Akane, Kagimura Tatsuo, Narita Ichiei, American Society of Nephrology 2023, 2023/11/02, Without Invitation, English
  31. Epidemiology of Medical Kidney Disease in the Southwestern United States, 1989-2018, Takahashi A, Miyauchi T, Kevin Ren KYM, Doi T, Masaki T, Yamashita M, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  32. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients, Ookubo A, Doi T, Nishizawa Y, Shigemoto K, Mizuiri S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  33. The Effect of Predilution Online Hemodiafiltration on Body Composition, Nutritional Status, and Mortality, Mizuiri S, Nishizawa Y, Okubo A, Doi T, Yamashita K, Shigemoto K, Usui K, Michiko Arita, Naito T, Doi S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  34. Coronary Artery Calcification Is a Risk Factor for Intradialytic Hypotension in Hemodialysis Patients, Mizuiri S, Nishizawa Y, Doi T, Yamashita K, Shigemoto K, Usui K, Arita M, Naito T, Doi S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  35. Identification of Factors Affecting Changes in the Agatston Coronary Artery Calcification Score in Maintenance Hemodialysis Patients, Morii K, Doi T, Nishizawa Y, Shigemoto K, Mizuiri S, Masaki T, 2021 American Society of Nephrology(ASN)Kidney Week, 2021/11/04, Without Invitation, English
  36. Inhibition of H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  37. TGF-b1 promotes fibrotic gene expression through induction of histone variant H3.3 and histone chaperone HIRA, Toshihiro Shindo, Shigehiro Doi, Kensuke Sasaki, Ayumu Nakashima, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  38. MicroRNA-200c is involved in Klotho reduction by oxidative stress in human tubular cells, Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Kensuke Sasaki, Toshinori Ueno, Ayumu Nakashima, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  39. Prognostic Factors in sepsis patients who have undergone direct hemoperfusion with polymyxin b-immobilized fibers, Aiko Okubo, Ayumu Nakashima, Shigehiro Doi, Toshihiro Ueno, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  40. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental renal fibrosis by their strong immunosuppressive effects, Ken Yoshida, Ayumu Nakashima, Shigehiro Doi, Toshinori Ueno, Yukio Kato, Yukihito Higashi, Takao Masaki, ISN FRONTIERS MEETINGS 2018, 2018/02/22, Without Invitation, English
  41. Inhibition of H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis, Ryo Tamura, Shigehiro Doi, Toshinori Ueno, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  42. TGF-b1 promotes fibrotic gene expression through induction of histone variant H3.3 and histone chaperone HIRA, Toshihiro Shindo, Shigehiro Doi, Kensuke Sasaki, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  43. MicroRNA-200c is involved in Klotho reduction by oxidative stress in human tubular cells, Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Kensuke Sasaki, Toshinori Ueno, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, Japanese
  44. Prognostic Factors in sepsis patients who have undergone direct hemoperfusion with polymyxin b-immobilized fibers, Aiko Okubo, Ayumu Nakashima, Shigehiro Doi, Toshihiro Ueno, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  45. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental renal fibrosis by their strong immunosuppressive effects, Ken Yoshida, Ayumu Nakashima, Shigehiro Doi, Toshinori Ueno, Yukio Kato, Yukihito Higashi, Takao Masaki, American Society of Nephrology 2017, 2017/10/31, Without Invitation, English
  46. Inhibitory Effect the Chromatin Histone H3-Lysine 4 Methyltransferase(SET7/9)on the Tubulointerstitial Fibrosis, Kensuke Sasaki, Ayumu Nakashima, Shigehiro Doi, Takao Masaki, American Society of Nephrology 2014, 2014/11/11, Without Invitation, English
  47. Mizoribine Suppressed Pyroptosis and Ameliorated Renal Inflammation in Aldosterone-Salt Treated Rats, Toshiki Doi, Shigehiro Doi, Ayumu Nakashima, Takao Masaki, American Society of Nephrology 2013, 2013/11/06, Without Invitation, English
  48. High Glucose Promotes TGF-β1 Productiono by Inducing FOS Expression in Human Peritoneal Mesothelial Cells, Shigehiro Doi, Keiko Kokoroishi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology 2013, 2013/11/06, Without Invitation, English
  49. Serum Lipids Levels may be Underestimated in Patients on Hemodialysis, Toshinori Ueno, Shigehiro Doi, Toru Kawai, Takao Masaki, WCN 2014 Satellite Symposium Kidney and Lipids, 2013/06/06, Without Invitation, English, fukuoka
  50. Comparison of Survival rate between Hemodialysis and Peritoneal dialysis patients: A prospective cohort study with Propensity score matching, Mami Miyazaki, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  51. Klotho Deficiency Intensifies Hypoxia-Induced Expression of INF-a/b Through Upregulation of Rig-I, Asako Urabe, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  52. A Combination of Contrast Media and Radiation Increases DNA Damage and Delays DNA Damage Repair in Mouse Kidneys, Shu Fujino, Shigehiro Doi, Ayumu Nakashima, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  53. Combined Value of Geriatric Nutritional Risk Index, Body Composition, and Bone Mineral Density for Predicting Mortality of Hemodialysis Patients, Sonoo Mizuiri, Nishizawa Yoshiko, Kazuomi Yamashita, Shigehiro Doi, Shigemoto Kennichiro, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  54. Association Among Iron, Coronary Artery Calcification, and Mortality in Hemodialysis Patients, Sonoo Mizuiri, Nishizawa Yoshiko, Kazuomi Yamashita, Usui Kohji, Shigehiro Doi, Shigemoto Kennichiro, Toshiki Doi, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English
  55. Inhibition of Mineralocorticoid Receptor Ameliorates Salt-Sensitive Hypertension After Ischemic-Reperfusion Injury in Rats, Takumi Matsumoto, Shigehiro Doi, Ayumu Nakashima, Takao Masaki, American Society of Nephrology(ASN)Kidney Week2020, 2020/10/22, Without Invitation, English

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI, 2014, 2016
  2. KAKENHI, 2013, 2015
  3. KANENHI, 2016, 2018
  4. KAKENHI, 2017, 2020
  5. KAKEN, 2016, 2018
  6. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2017, 2019
  7. KAKENHI, 2019, 2022
  8. KAKENHI, 2016, 2018

Social Activities

Organizing Academic Conferences, etc.

  1. e 5th Annual Meeting of Japanese Society for Artificial Intelligence in Nephrology and Blood Purifcation, 2025/10, 2025/10
  2. The 32th Annual Meeting of the Chugoku Society for Renal Failure, 2022/12, 2022/12
  3. The 27th Annual Meeting of Japanese Society for Hemodiafiltration, 2021/10, 2021/10

History as Peer Reviews of Academic Papers

  1. 2023, Clinical and Experimental Nephrology, Editor
  2. 2024, Clinical and Experimental Nephrology, Editor
  3. 2025, Clinical and Experimental Nephrology, Editor
  4. 2022, Clinical and Experimental Nephrology, Editor
  5. 2021, Clinical and Experimental Nephrology, Editor